Caplin Point Laboratories Limited

UTI Mutual Fund decreased its stake in Caplin Point Laboratories from 1.85% to 1.81%, selling 30,340 shares. This transaction is valued at approximately ₹7.58 Cr based on the share price of ₹2499.70.

A pharmaceutical manufacturer engaged in producing active pharmaceutical ingredients and finished formulations with integrated research and development capabilities. Caplin Point Laboratories operates across multiple geographies including Latin America, Africa, and the United States, serving both domestic and international markets. The company combines API manufacturing with clinical research operations, positioning itself as a vertically integrated player in the global healthcare sector with a diverse product portfolio.

India's oldest and most storied asset manager, founded in 1963 as the Unit Trust of India under an Act of Parliament. Now manages over Rs 3.5 lakh crore with backing from four public sector institutions: LIC, SBI, Bank of Baroda, and Punjab National Bank. CIO Vetri Subramaniam is a long-term compounder with a consistent quality tilt and clear articulation of process.